Voriconazole as mono-therapy in orbitofrontal erosive aspergillosis without gross total resection: A case report and review of literature

Clin Neurol Neurosurg. 2018 Sep:172:93-95. doi: 10.1016/j.clineuro.2018.06.043. Epub 2018 Jul 2.

Abstract

In this case report we present an immunocompetent 64-year-old patient presenting with an orbitofrontal invasive aspergillosis treated successfully with voriconazole monotherapy following biopsy and orbital decompression.

Keywords: Aspergillosis; Brain; CNS; Voriconazole.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Aspergillosis / drug therapy*
  • Aspergillosis / pathology
  • Biopsy
  • Humans
  • Immunocompetence / drug effects
  • Male
  • Middle Aged
  • Triazoles / therapeutic use*
  • Voriconazole / therapeutic use*

Substances

  • Antifungal Agents
  • Triazoles
  • Voriconazole